3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Arne Astrup et al.|The Lancet|2017Cited by 843
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)Massimiliano Caprio, Riccarda Granata, Eleonora Poggiogalle et al.|Journal of Endocrinological Investigation|2019Cited by 292
The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2)Margherita Maffei, Ferruccio Santini|BMC Biology|2009Cited by 54
A Novel Evaluation of 24-hour Energy Metabolism in Cushing's Syndrome: The Metabolic Cost of HypercortisolismAlessio Basolo, Ferruccio Santini|Journal of the Endocrine Society|2025Cited by 0